MDT

96.37

+0.09%↑

A

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

A

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

A

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

A

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

MDT

96.37

+0.09%↑

A

136.66

-0.28%↓

VEEV

223.77

-0.18%↓

HQY

91.94

-0.73%↓

PHR.US

16.89

-0.59%↓

Search

iRhythm Technologies Inc

Avatud

SektorTervishoid

177.86 0.04

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

175.54

Max

178.61

Põhinäitajad

By Trading Economics

Sissetulek

9M

-5.2M

Müük

6.2M

193M

Kasumimarginaal

-2.702

Töötajad

2,000

EBITDA

7.7M

2.4M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+23.65% upside

Turustatistika

By TradingEconomics

Turukapital

-116M

5.8B

Eelmine avamishind

177.82

Eelmine sulgemishind

177.86

Uudiste sentiment

By Acuity

16%

84%

25 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

iRhythm Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. dets 2025, 23:49 UTC

Omandamised, ülevõtmised, äriostud

WiseTech to Sell Expedient to Appease Competition Regulator

30. dets 2025, 17:12 UTC

Suurimad hinnamuutused turgudel

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

30. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. dets 2025, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

30. dets 2025, 21:08 UTC

Market Talk

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

30. dets 2025, 20:41 UTC

Market Talk

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

30. dets 2025, 20:37 UTC

Tulu

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

30. dets 2025, 19:29 UTC

Market Talk

Corn Extends Pullback in Light Trade -- Market Talk

30. dets 2025, 18:29 UTC

Market Talk

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

30. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. dets 2025, 16:20 UTC

Tulu

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

30. dets 2025, 16:18 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

30. dets 2025, 16:10 UTC

Market Talk

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

30. dets 2025, 15:24 UTC

Market Talk

Australian Dollar Could Rise Versus Sterling -- Market Talk

30. dets 2025, 15:10 UTC

Omandamised, ülevõtmised, äriostud

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

30. dets 2025, 14:24 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

30. dets 2025, 14:22 UTC

Omandamised, ülevõtmised, äriostud

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

30. dets 2025, 14:20 UTC

Omandamised, ülevõtmised, äriostud

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

30. dets 2025, 14:17 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

30. dets 2025, 14:16 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

30. dets 2025, 14:14 UTC

Omandamised, ülevõtmised, äriostud

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

30. dets 2025, 14:12 UTC

Omandamised, ülevõtmised, äriostud

LVMH: Les Editions Croque Futur Is a French Publishing House

30. dets 2025, 14:10 UTC

Omandamised, ülevõtmised, äriostud

LVMH Acquires Les Editions Croque Futur

30. dets 2025, 13:49 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

30. dets 2025, 13:36 UTC

Market Talk

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

30. dets 2025, 13:30 UTC

Market Talk

Crude Futures Gain in Light Holiday Trade -- Market Talk

30. dets 2025, 12:55 UTC

Market Talk

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

30. dets 2025, 11:55 UTC

Market Talk
Tulu

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

30. dets 2025, 11:47 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

30. dets 2025, 11:35 UTC

Omandamised, ülevõtmised, äriostud

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

iRhythm Technologies Inc Prognoos

Hinnasiht

By TipRanks

23.65% tõus

12 kuu keskmine prognoos

Keskmine 220.83 USD  23.65%

Kõrge 244 USD

Madal 202 USD

Põhineb 13 Wall Streeti analüütiku instrumendi iRhythm Technologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

13 ratings

12

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

104.78 / 137.91Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

25 / 374 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat